re: valuation - 2$, only tiof blue sky I get a valuation of 1.23$ per share with Chinguetti, Tevet, and Cash, and no "blue sky" at all.
Most of us know there is MORE THAN THIS with Hardman.
Tiof itself could be worth over 1$ per share once it is commercial. At the moment its "blue sky" value would be around 0.75$, i.e placing a chance of success of 0.75. Declaration of Commerciality of Tiof would bring the chance of success up to 1 and therefore no more blue sky with Tiof.
So a valuation taking into account Chinguetti, Tevet, and Cash, and Tiof with chance of success of 0.75 gives us per share:
1.23 + 0.75 = 1.98
i.e. around 2$ per share. This is not considering any blue sky at all other than Tiof which so far is getting closer to success (e.g. Tiof 3 very successful), and assuming Tevet will go ahead (easily tied back to Chinguetti). Chinguetti, we all know by now, is a definite go-ahead.
So 1.84$ per share is cheap if you think that there will be any further success at all in the remainder of the program.
- Forums
- ASX - By Stock
- HDR
- we need a new md - and we need him/her now!!
HDR
hardman resources limited
we need a new md - and we need him/her now!!, page-13
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Currently unlisted public company.
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online